PLACE OF THE 18F-FDG-PET/CT IN THE DIAGNOSTIC WORKUP IN PATIENTS WITH CLASSICAL FEVER OF UNKNOWN ORIGIN (FUO)
1 other identifier
observational
44
1 country
1
Brief Summary
Objective : To explore the diagnostic contribution of the 18F-FDG-PET/CT in a population of patients with classical fever of unknown origin (FUO), to precise its place in the diagnostic decision tree in a real-life setting and to identify factors associated with a diagnostic 18F-FDG-PET/CT. Methods: All adult patients (age≥18 years) with a diagnosis of classical FUO who underwent a 18F-FDG-PET/CT in the University Hospital of Montpellier (France) between April 2012 and December 2017 were included. True positive 18F-FDG-PET/CT which evidenced a specific disease causing FUO were considered to be contributive.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
April 13, 2021
CompletedFirst Posted
Study publicly available on registry
April 20, 2021
CompletedApril 20, 2021
April 1, 2021
3 months
April 13, 2021
April 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the diagnostic contribution of the 18F-FDG-PET/CT
the diagnostic contribution of the 18F-FDG-PET/CT in a population of patients with classical FUO.
day 1
Secondary Outcomes (2)
18F-FDG-PET/CT place in the diagnostic decision tree in a real-life setting
day 1
factors associated with a diagnostic 18F-FDG-PET/CT.
day 1
Eligibility Criteria
This retrospective study included all adult patients (age≥18 years) with a diagnosis of classical FUO who underwent a 18F-FDG-PET/CT in the University Hospital of Montpellier (France) between April 2012 and December 2017.
You may qualify if:
- age≥18 years
- a diagnosis of classical FUO who underwent a 18F-FDG-PET/CT
You may not qualify if:
- refusal to participate-
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University hospital of Montpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Camille ROUBILLE, MCUPH
UH MONTPELLIER
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2021
First Posted
April 20, 2021
Study Start
December 8, 2020
Primary Completion
March 1, 2021
Study Completion
April 1, 2021
Last Updated
April 20, 2021
Record last verified: 2021-04